Maas AHEM

ORCID: 0000-0001-5782-9926 · 5 papers in corpus
guideline 2026
Global heart ·doi:10.5334/gh.1576

Extending women's health-span is a key challenge for the medical community. Although women live longer than men, they face a higher burden of chronic diseases, such as cardiovascular diseases (CVDs) and disabilities. Endogenous estrogens ap…

observational 2024
JACC. CardioOncology ·doi:10.1016/j.jaccao.2024.09.011

BACKGROUND: Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, e…

review 2024
Maturitas ·doi:10.1016/j.maturitas.2024.107970

There is an increasing interest among professionals in cardiovascular medicine in women-specific risk variables related to gynecologic conditions over the life span. Although adverse lifestyle factors, hypertension, dyslipidemia and insulin…

nonrandomized-trial 2021
JAMA oncology ·doi:10.1001/jamaoncol.2021.1590

IMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophorectomy (RRSO). Becaus…

guideline 2021
European heart journal ·doi:10.1093/eurheartj/ehaa1044

Women undergo important changes in sex hormones throughout their lifetime that can impact cardiovascular disease risk. Whereas the traditional cardiovascular risk factors dominate in older age, there are several female-specific risk factors…